- Part 23: For the preceding part double click ID:nRSH4027Rv
enforcing their own anti-bribery laws more aggressively and/or adopting
tougher new measures.We are the subject of current anti-corruption
investigations and there can be no assurance that we will not, from time
to time, continue to be subject to informal inquiries and formal
investigations from governmental agencies. In the context of our
business, governmental officials interact with us in various roles that
are important to our operations, such as in the capacity of a regulator,
partner or healthcare payer, reimburser or prescriber, among others.
Details of these matters are included in Note 27 to the Financial
Statements from page 186.
Failure to adhere to applicable laws, rules and regulations Impact
Any failure to comply with applicable laws, rules and regulations may Failure to comply with applicable laws, including ongoing control and regulation, could materially adversely affect our business or results of operations. For example, once a product has been approved for marketing by the regulatory authorities, it is subject to continuing control and regulation, such as the manner of its manufacture, distribution, marketing and safety surveillance. For example, if regulatory issues concerning compliance with current Good Manufacturing Practice or safety monitoring regulations for pharmaceutical products (often referred to as pharmacovigilance) arise, this could lead to loss of product approvals, product recalls and seizures, and interruption of production, which could create product shortages and delays in new product approvals, and negatively impact patient access and our reputation.
- More to follow, for following part double click ID:nRSH4027Rx